Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Melanoma × Opdualag × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 14 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Brain Neoplasms 2 Uveal Melanoma 1 Patient Preference 1 Lymphoma 1 Locally Advanced Melanoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1

Interventions

relatlimab 1 cemiplimab 1 Opdualag 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07223411 2025-11-26

Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

University of Pittsburgh

Locally Advanced Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡